Sort
82,697 grants matching “vaccine development”
Influence of maternal virome and HIV status on infant gut virome, growth and immunity
$745,594Heather Beryl Jaspan · Seattle Children'S Hospital · R01 · FY2021 · HD
Chemoenzymatic synthesis of bacterial polysaccharides
$745,518Hai Yu · University Of California At Davis · U01 · FY2018 · GM
Developing a Multi-epitope Pan-Coronavirus Vaccine
$745,410Lbachir Benmohamed · University Of California-Irvine · R01 · FY2020 · AI
Novel Methods to Inform HIV/TB Clinical Trial Development
$745,409Rochelle P Walensky · Massachusetts General Hospital · R37 · FY2017 · AI
Increasing HPV Vaccine Uptake in a Low Income Ethnic Minority Population
$745,403Roshan Bastani · University Of California Los Angeles · R01 · FY2012 · CA
Impact of Early-life Exposure to Semi-Volatile Organic Compounds (SVOCs) on Neonatal and Early Childhood Immune Function
$745,302Jennifer K Hoffman · Duke University · R01 · FY2025 · AI
Deciphering innate and adaptive immune responses to Rickettsia parkeri
$745,295Thomas P Burke · University Of California-Irvine · R01 · FY2025 · AI
In Vivo Mechanisms of Antibody-mediated Protection from Aerosolized Ricin Toxin
$745,291Seth H. Pincus · Montana State University - Bozeman · R56 · FY2017 · AI
CCR5-mutant monkey model to facilitate the development of novel stem cell-based therapies for AIDS
$745,261Igor I Slukvin · University Of Wisconsin-Madison · R24 · FY2018 · OD
An integrated fiber-microneedle device to study and optimize immune responses
$745,214Kim A. Woodrow · University Of Washington · R56 · FY2020 · DE
Prevention Umbrella for MSM in the Americas
$745,211Susan Buchbinder · Public Health Foundation Enterprises · R01 · FY2009 · AI
Role of alterations in the ATII cell lipidome in influenza pathogenesis
$745,184Ian Christopher Davis · Ohio State University · R01 · FY2020 · HL
Advancement of poxvirus inhibitor
$745,122John H Connor · Boston University Medical Campus · R01 · FY2024 · AI
T cell Immunity and the Outcome of Acute HCV Infection
$745,107Christopher M. Walker · Research Inst Nationwide Children'S Hosp · R01 · FY2018 · AI
Mucosal subunit vaccines against SARS CoV-2
$745,036Purnima Dubey · Ohio State University · R01 · FY2025 · AI
Mechanisms of effective antibody neutralization
$745,029Niraj Tolia · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Host Genetics of HIV-1 Subtype C Infection, Progression, and Treatment in Africa
$745,015Myron E Essex · Harvard School Of Public Health · R01 · FY2009 · AI
Clinical Trials and Ancillary Assays
$745,000Harriet L Robinson · Geovax, Inc. · U19 · FY2010 · AI
Exploring the role of T cells in protection from respiratory virus transmission
$744,977Jacob E Kohlmeier · Emory University · R01 · FY2025 · AI
Childhood infection and prevention of obesity
$744,972Julie Parsonnet · Stanford University · R01 · FY2009 · HD
Heterosubtypic immunity to influenza virus mediated by MHC-E-restricted memory NK cells
$744,953Stephanie Jost · Duke University · R01 · FY2025 · AI
NJMS Clinical Trials Unit: Targeting Pediatric, Adolescent, and Material HIV Infe
$744,915James Oleske · Univ Of Med/Dent Of Nj-Nj Medical School · U01 · FY2009 · AI
The Consequences of Reinfection with M. tuberculosis
$744,863Joanne L. Flynn · University Of Pittsburgh At Pittsburgh · R01 · FY2018 · AI
Early Events in Mucosal SIV Pathogenesis
$744,861Ronald S. Veazey · Tulane University Of Louisiana · R01 · FY2012 · AI
Molecular and structural characterization of broadly neutralizing anti-HCV antibodies
$744,817Justin Richard Bailey · Johns Hopkins University · R01 · FY2017 · AI